<?xml version="1.0" encoding="UTF-8"?>
<iati-activities version="2.02">
 <iati-activity hierarchy="1" iati-activities:version="2.02" xml:lang="EN" xmlns:iati-activities="http://d-portal.org/xmlns/iati-activities">
  <iati-identifier>XM-DAC-903-SPI-31253</iati-identifier>
  <reporting-org ref="XM-DAC-903" type="40">
   <narrative xml:lang="EN">International Finance Corporation</narrative>
  </reporting-org>
  <title>
   <narrative xml:lang="EN">Granules II</narrative>
  </title>
  <description type="2">
   <narrative xml:lang="EN">- The Project will significantly demonstrate how domestic companies use their strong comparative advantages of low cost of production and scale to exploit the opportunities that enable them to move up the pharmaceutical value chain in selling to more regulated markets.
- The Project will support the Company&apos;s expansion enabling wider availability of high quality, low cost drugs in developed and developing markets.</narrative>
  </description>
  <description type="1">
   <narrative xml:lang="EN">Granules India Limited (Granules or the Company) an existing IFC client is a leading Contract Manufacturing Organization supplying high volume Active Pharmaceutical Ingredients, Pharmaceutical Formulation Intermediates (PFIs) and finished formulations to the bulk over-the-counter drugs industry in the US, Europe, Latin America, Australia and India. Granules has three wholly-owned manufacturing plants near Hyderabad in India (Jeedimetla, Bonthapally, and Gagillapur) and one plant in China through a 50:50 joint venture.

The company is undertaking an investment program (the Project) estimated to cost about $22 million, comprising of: expanding the capacity of its multi-product tableting plant, expanding the capacity of its PFI plant and expanding its warehousing capacity.</narrative>
  </description>
  <participating-org role="4" type="70">
   <narrative xml:lang="EN">GRANULES INDIA LIMITED</narrative>
  </participating-org>
  <participating-org activity-id="XM-DAC-903-SPI-31253" ref="XM-DAC-903" role="1" type="40"></participating-org>
  <activity-status code="3"></activity-status>
  <activity-date iso-date="2011-09-29" type="1"></activity-date>
  <activity-date iso-date="2011-12-08" type="2"></activity-date>
  <contact-info type="1">
   <organisation>
    <narrative xml:lang="EN">International Finance Corporation</narrative>
   </organisation>
   <telephone>+12024733800</telephone>
   <email>ccspg@ifc.org</email>
   <website>www.ifc.org</website>
   <mailing-address>
    <narrative xml:lang="EN">2121 Pennsylvania Avenue, NW Washington DC 20433</narrative>
   </mailing-address>
  </contact-info>
  <contact-info type="2">
   <mailing-address>
    <narrative xml:lang="EN">Mr. BVRK Srinivas  AVP Formulations
Address: 	
Granules India Limited
Plot No. 160/A &amp; 161/E,
Gagillapur Village,
Qutubullapur Mandal,
RR District - 500 043

Tel: +91 8418 255233, 257222, 257121
Email id: srinivas.bvrk@granulesindia.com</narrative>
   </mailing-address>
  </contact-info>
  <contact-info type="2">
   <mailing-address>
    <narrative xml:lang="EN"></narrative>
   </mailing-address>
  </contact-info>
  <recipient-country code="IN" percentage="100">
   <narrative xml:lang="EN">India</narrative>
  </recipient-country>
  <location ref="IN-India">
   <location-reach code="1"></location-reach>
   <location-id code="1453782" vocabulary="G1"></location-id>
   <name>
    <narrative xml:lang="EN">The project site is Gagillapur in Hyderabad, India. Granules has an existing plant located at the same site (an industrial zone near the village of Gagillapur). The site is well connected by road to Hyderabad.</narrative>
   </name>
   <description>
    <narrative xml:lang="EN">Location description</narrative>
   </description>
   <activity-description>
    <narrative xml:lang="EN">A description that qualifies the activity taking place at the location.</narrative>
   </activity-description>
   <administrative code="1453782" level="1" vocabulary="G1"></administrative>
   <point srsName="http://www.opengis.net/def/crs/EPSG/0/4326">
    <pos>22.0000000000 79.0000000000</pos>
   </point>
   <exactness code="2"></exactness>
   <location-class code="1"></location-class>
   <feature-designation code="ADMF"></feature-designation>
  </location>
  <sector percentage="100" vocabulary="11" vocabulary-uri="http://www.census.gov/cgi-bin/sssd/naics/naicsrch?chart=2012">
   <narrative xml:lang="EN">FA - Pharmaceuticals and Medicine</narrative>
  </sector>
  <country-budget-items vocabulary="1">
   <budget-item code="7.2.1" percentage="100" vocabulary="1">
    <description>
     <narrative xml:lang="EN">Total: $10.00 million</narrative>
    </description>
   </budget-item>
  </country-budget-items>
  <collaboration-type code="6"></collaboration-type>
  <default-flow-type code="35"></default-flow-type>
  <default-finance-type code="411"></default-finance-type>
  <default-aid-type code="C01" vocabulary="1"></default-aid-type>
  <default-tied-status code="5"></default-tied-status>
  <budget type="1">
   <period-start iso-date="2011-09-29"></period-start>
   <period-end iso-date="2012-06-30"></period-end>
   <value currency="USD" value-date="2011-09-29">10000000</value>
  </budget>
  <transaction>
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2011-09-29"></transaction-date>
   <value currency="USD" value-date="2011-09-29">10000000</value>
   <receiver-org>
    <narrative xml:lang="EN">GRANULES INDIA LIMITED</narrative>
   </receiver-org>
   <flow-type code="35"></flow-type>
   <finance-type code="411"></finance-type>
  </transaction>
  <document-link format="TEXT/HTML" url="https://disclosures.ifc.org/project-detail/SPI/31253/granules-ii">
   <title>
    <narrative xml:lang="EN">Summary of Project Information</narrative>
   </title>
   <category code="A12"></category>
   <language code="EN"></language>
  </document-link>
 </iati-activity>
</iati-activities>
